Literature DB >> 24913708

Establishment of experimental implantation tumor models of hepatocellular carcinoma in Wistar rats.

Yi Jin1, Dayue Tong, Junjie Shen, Jianyong Yang, Jiaping Li.   

Abstract

Our aims were to investigate and establish simple and reliable implanted hepatocellular carcinoma (HCC) models in Wistar rats. Concentrated suspensions of CBRH-7919 cancer cell lines were injected subcutaneously into the scapular regions of nude mice. The developing tumor tissues were then implanted into the livers of 45 adult Wistar rats. Dexamethasone (2.5 mg/day) was injected intramuscularly daily for 1 week preoperatively and 2 weeks postoperatively. After 4 weeks of implantation, ultrasonography and nuclear magnetic resonance imaging (MRI) were performed to identify model rats with liver tumor growth and to analyze the growth and characteristics of the tumors. Five of these model rats were then sacrificed, and the tumors were removed from the liver for pathological examination. Three rats died during the operation; among the remaining 42 rats, 36 possessed a total of 43 liver tumors. The success rate of tumor implantation was 85.7 % (36/42), and the diameters of the tumors ranged from 5 to 10 mm. All tumor specimens were confirmed to be HCC by pathological examination. This study provides a new approach for establishing implanted HCC models in Wistar rats, which can be used for studying numerous biological features of HCC.

Entities:  

Mesh:

Year:  2014        PMID: 24913708     DOI: 10.1007/s13277-014-2161-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  19 in total

Review 1.  Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma.

Authors:  Bhavna Rani; Yuan Cao; Andrea Malfettone; Ciprian Tomuleasa; Isabel Fabregat; Gianluigi Giannelli
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 2.  Adjuvant therapy after curative resection for hepatocellular carcinoma associated with hepatitis virus.

Authors:  Shoji Kubo; Shigekazu Takemura; Chikaharu Sakata; Yorihisa Urata; Takahiro Uenishi
Journal:  Liver Cancer       Date:  2013-01       Impact factor: 11.740

3.  Xenografts of human hepatocellular carcinoma: a useful model for testing drugs.

Authors:  Hung Huynh; Khee Chee Soo; Pierce K H Chow; Lawrence Panasci; Evelyn Tran
Journal:  Clin Cancer Res       Date:  2006-07-15       Impact factor: 12.531

4.  Establishment of an orthotopic transplantation tumor model of hepatocellular carcinoma in mice.

Authors:  Gui-Jun Zhao; Li-Xia Xu; Eagle S H Chu; Ning Zhang; Jia-Yun Shen; Alatangaole Damirin; Xiao-Xing Li
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 5.  Clinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and future.

Authors:  Hwi Young Kim; Joong-Won Park
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

6.  Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosis.

Authors:  Miroslaw Kornek; Esther Raskopf; Rene Tolba; Ursula Becker; Maren Klöckner; Tilman Sauerbruch; Volker Schmitz
Journal:  Liver Int       Date:  2008-04       Impact factor: 5.828

Review 7.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

Review 8.  Experimental models of hepatocellular carcinoma.

Authors:  Philippa Newell; Augusto Villanueva; Scott L Friedman; Kazuhiko Koike; Josep M Llovet
Journal:  J Hepatol       Date:  2008-01-30       Impact factor: 25.083

9.  Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma.

Authors:  Hiroki Nishikawa; Akira Arimoto; Tomoko Wakasa; Ryuichi Kita; Toru Kimura; Yukio Osaki
Journal:  J Cancer       Date:  2013-07-18       Impact factor: 4.207

10.  Clinical significance and gene expression study of human hepatic stellate cells in HBV related-hepatocellular carcinoma.

Authors:  Rui Liao; Han Wu; Yong Yi; Jia-Xing Wang; Xiao-Yan Cai; Hong-Wei He; Yun-Feng Cheng; Jian Zhou; Jia Fan; Jian Sun; Shuang-Jian Qiu
Journal:  J Exp Clin Cancer Res       Date:  2013-04-19
View more
  2 in total

1.  In vivo longitudinal study of rodent skeletal muscle atrophy using ultrasonography.

Authors:  Antonietta Mele; Adriano Fonzino; Francesco Rana; Giulia Maria Camerino; Michela De Bellis; Elena Conte; Arcangela Giustino; Diana Conte Camerino; Jean-François Desaphy
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

2.  Bufalin-loaded bovine serum albumin nanoparticles demonstrated improved anti-tumor activity against hepatocellular carcinoma: preparation, characterization, pharmacokinetics and tissue distribution.

Authors:  Huiqing Zhang; Nian Huang; Geliang Yang; Qing Lin; Yonghua Su
Journal:  Oncotarget       Date:  2017-06-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.